Pivotal Role of Akt Activation in Mitochondrial Protection and Cell Survival by Poly(ADP-ribose)polymerase-1 Inhibition in Oxidative Stress
Open accessThe DOI matches its Crossref record; 40 of the 58 references it cites were found in a registry or an index, and 18 are not checked yet.
Abstract
According to the classical view, the cytoprotective effect of inhibitors of poly(ADP-ribose)polymerase (PARP) in oxidative stress was based on the prevention of NAD+ and ATP depletion, thus the attenuation of necrosis. Our previous data on PARP inhibitors in an inflammatory model suggested that PARP-catalyzed ADP-ribosylations may affect signaling pathways, which can play a significant role in cell survival. To clarify the molecular mechanism of cytoprotection, PARP activity was inhibited pharmacologically by suppressing PARP-1 expression by a small interfering RNA (siRNA) technique or by transdominantly expressing the N-terminal DNA-binding domain of PARP-1 (PARP-DBD) in cultured cells. Cell survival, activation of the phosphatidylinositol 3-kinase (PI3-kinase)/Akt system, and the preservation of mitochondrial membrane potential were studied in hydrogen peroxide-treated WRL-68 cells. Our data showed that suppression of the single-stranded DNA break-induced PARP-1 activation by pharmacological inhibitor, siRNA, or by the transdominant expression of PARP-DBD protected cells from oxidative stress and induced the phosphorylation and activation of Akt. Furthermore, prevention of Akt activation by inhibiting PI3-kinase counteracted the cytoprotective effect of PARP inhibition. Microscopy data showed that PARP inhibition-induced Akt activation was responsible for protection of mitochondria in oxidative stress because PI3-kinase inhibitors diminished the protective effect of PARP in…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In our study, we observed that olaparib induces the activation of AKT, as a response to cellular stressors, aligning with findings from previous research [44].”
From Celastrol attenuates the invasion and migration and augments the anticancer effects of olaparib in prostate cancer (2024) · cites this paper as [44]
Citations
Cites
Vlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,240
Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor
Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A., & Connelly, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.695 · Cited by 1,939
Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
Yu, S.-W., Wang, H., Poitras, M. F., Coombs, C., Bowers, W. J., Federoff, H. J., Poirier, G. G., Dawson, T. M., & Dawson, V. L. (2002) · Science · doi:10.1126/science.1072221 · Cited by 1,826
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
d'AMOURS, D., DESNOYERS, S., d'SILVA, I., & POIRIER, G. G. (1999) · Biochemical Journal · doi:10.1042/bj3420249 · Cited by 1,815
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
Virág, L., & Szabó, C. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.375 · Cited by 1,373
Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia
Eliasson, M. J. L., Sampei, K., Mandir, A. S., Hurn, P. D., Traystman, R. J., Bao, J., Pieper, A., Wang, Z.-Q., Dawson, T. M., Snyder, S. H., et al. (1997) · Nature Medicine · doi:10.1038/nm1097-1089 · Cited by 1,018
Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion
Ha, H. C., & Snyder, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13978 · Cited by 907
Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors
Jagtap, P., & Szabó, C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1718 · Cited by 896
Poly(ADP-ribose) polymerase: a molecular nick-sensor
de Murcia, G., & de Murcia, J. M. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90280-1 · Cited by 797
Poly(ADP-Ribose) in the Cellular Response to DNA Damage
Berger, N. A. (1985) · Radiation Research · doi:10.2307/3576299 · Cited by 775
Research works printed but not linked: 7
- Turners, 1980, Biochem. J., 156, 434
- McCord, 1987, Fed. Proc., 46, 2402
- Palfi, 2005, J. Pharmacol. Exp. Ther.
- Wesierska-Gadek, 2001, Cell. Mol. Biol. Lett., 6, 117
- Amstad, 1992, Cancer Res., 52, 3952
- Powis, 1994, Cancer Res., 54, 2419
- Komjati, 2004, Int. J. Mol. Med., 13, 373
Cited by
Nuclear ADP-Ribosylation Reactions in Mammalian Cells: Where Are We Today and Where Are We Going?
Hassa, P. O., Haenni, S. S., Elser, M., & Hottiger, M. O. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00040-05 · Cited by 682
Nitric oxide, cell bioenergetics and neurodegeneration
Moncada, S., & Bolaños, J. P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03988.x · Cited by 556
“Interestingly, NO affords protection against O2 ) (Oury et al. 1992; Lafon-Cazal et al. 1993; Rauhala et al. 1998; Mohanakumar et al. 2002) and H2O2-mediated cytotoxicity (Chang et al. 1996; Wink et al. 1996).”
BackgroundInfluentialBiology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance
Bai, P. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.034 · Cited by 442
“, sepsis, endotoxic, or haemorrhagic shock) and graft-versus-host reaction (Rosado et al., 2013; Virág and Szabó, 2002).”
InfluentialActivation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer
Dong, C., Wu, J., Chen, Y., Nie, J., & Chen, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.628690 · Cited by 375
Kim, H., Xu, H., George, E., Hallberg, D., Kumar, S., Jagannathan, V., Medvedev, S., Kinose, Y., Devins, K., Verma, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17127-2 · Cited by 362
Poly(ADP-ribose) signaling in cell death
Virág, L., Robaszkiewicz, A., Rodriguez-Vargas, J. M., & Oliver, F. J. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.01.007 · Cited by 273
PARP-1 is involved in autophagy induced by DNA damage
Muñoz-Gámez, J. A., Rodríguez-Vargas, J. M., Quiles-Pérez, R., Aguilar-Quesada, R., Martín-Oliva, D., de Murcia, G., de Murcia, J. M., Almendros, A., de Almodóvar, M. R., & Oliver, F. J. (2009) · Autophagy · doi:10.4161/auto.5.1.7272 · Cited by 247
PARP inhibitors: Clinical utility and possibilities of overcoming resistance
Bitler, B. G., Watson, Z. L., Wheeler, L. J., & Behbakht, K. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.10.003 · Cited by 217
Signaling Mechanism of Poly(ADP-Ribose) Polymerase-1 (PARP-1) in Inflammatory Diseases
Ba, X., & Garg, N. J. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.12.004 · Cited by 211
Poly(ADP-ribose): PARadigms and PARadoxes
Bürkle, A., & Virág, L. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.12.010 · Cited by 195
“Tapodi et al. (2005) CaMK-II5”
Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance
Kim, D.-S., Camacho, C. V., & Kraus, W. L. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00557-3 · Cited by 164
PARP-1 Regulates Metastatic Melanoma through Modulation of Vimentin-induced Malignant Transformation
Rodríguez, M. I., Peralta-Leal, A., O’Valle, F., Rodríguez-Vargas, J. M., González-Flores, A., Majuelos‐Melguizo, J., López, L., Serrano, S., de Herreros, A. G., Rodríguez-Manzaneque, J. C., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003531 · Cited by 140
Mudassar, F., Shen, H., O’Neill, G., & Hau, E. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01724-6 · Cited by 129
“Activation of the Akt system also phosphorylates various downstream regulatory proteins such as BAD, caspase-9, FKHR, and GSK3β, which protects against cellular stress [137].”
BackgroundMathews, M. T., & Berk, B. C. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.156406 · Cited by 120
Poly(ADP-ribose) polymerases as modulators of mitochondrial activity
Bai, P., Nagy, L., Fodor, T., Liaudet, L., & Pacher, P. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.11.003 · Cited by 129
Rajesh, K., Krishnamoorthy, J., Kazimierczak, U., Tenkerian, C., Papadakis, A. I., Wang, S., Huang, S., & Koromilas, A. E. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.554 · Cited by 136
Hocsak, E., Szabo, V., Kalman, N., Antus, C., Cseh, A., Sumegi, K., Eros, K., Hegedus, Z., Gallyas, F., Sumegi, B., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.018 · Cited by 109
Self-citationInhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death
Veto, S., Acs, P., Bauer, J., Lassmann, H., Berente, Z., Setalo, G., Borgulya, G., Sumegi, B., Komoly, S., Gallyas, F., et al. (2010) · Brain · doi:10.1093/brain/awp337 · Cited by 107
“This crosstalk is supposed to involve a PARP-dependent activation of c-Jun N-terminal kinase (JNK) and the cytoprotective phosphoinositol-3 kinase-Akt pathway (Tapodi et al., 2005; Xu et al., 2006).”
Self-citationPARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington’s Disease
Cardinale, A., Paldino, E., Giampà, C., Bernardi, G., & Fusco, F. R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134482 · Cited by 103
“Inhibition of PARP by specific compounds can prevent the release of AIF to the nucleus and therefore is protective for the cell [27, 28].”
BackgroundPoly(ADP-ribose) glycohydrolase silencing protects against H2O2-induced cell death
Blenn, C., Althaus, F. R., & Malanga, M. (2006) · Biochemical Journal · doi:10.1042/bj20051696 · Cited by 98
Kim, T. W., Cho, H. M., Choi, S. Y., Suguira, Y., Hayasaka, T., Setou, M., Koh, H. C., Mi Hwang, E., Park, J. Y., Kang, S. J., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.447 · Cited by 95
Activation of mitochondrial fusion provides a new treatment for mitochondria-related diseases
Szabo, A., Sumegi, K., Fekete, K., Hocsak, E., Debreceni, B., Setalo, G., Kovacs, K., Deres, L., Kengyel, A., Kovacs, D., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.038 · Cited by 92
Self-citationVulnerabilities of PTEN – TP53 -Deficient Prostate Cancers to Compound PARP–PI3K Inhibition
González-Billalabeitia, E., Seitzer, N., Song, S. J., Song, M. S., Patnaik, A., Liu, X.-S., Epping, M. T., Papa, A., Hobbs, R. M., Chen, M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0230 · Cited by 92
Shao, H., Li, T., Zhu, R., Xu, X., Yu, J., Chen, S., Song, L., Ramakrishna, S., Lei, Z., Ruan, Y., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.05.028 · Cited by 90
Ceramide in the Molecular Mechanisms of Neuronal Cell Death. The Role of Sphingosine-1-Phosphate
Czubowicz, K., & Strosznajder, R. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8606-4 · Cited by 89
The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer
Turnham, D. J., Bullock, N., Dass, M. S., Staffurth, J. N., & Pearson, H. B. (2020) · Cells · doi:10.3390/cells9112342 · Cited by 87
RAS and downstream RAF-MEK and PI3K-AKT signaling in neuronal development, function and dysfunction
Zhong, J. (2016) · Biological Chemistry · doi:10.1515/hsz-2015-0270 · Cited by 88
“PI3KAKT signaling also plays a protective role against diverse stresses in the mature CNS, for example, against ethanolinduced neural apoptosis (de la Monte et al., 2000) and oxidative stress (Tapodi et al., 2005).”
Fan, R., Li, X., Gu, X., Chan, J. C. N., & Xu, G. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01238.x · Cited by 82
“In mammalian cells, AKT activity is closely correlated with mitochondrial function [38].”
BackgroundPARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent
Éthier, C., Tardif, M., Arul, L., & Poirier, G. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047978 · Cited by 78
“This induction of Akt phosphorylation by PARP inhibitors has been observed previously [29,30] and might be attributed to the activation of DNA-protein kinase (DNA-PK) after DNA doublestranded breaks (DSB) that persist due to PARP inhibition [31].”
BackgroundMiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1
Vescarelli, E., Gerini, G., Megiorni, F., Anastasiadou, E., Pontecorvi, P., Solito, L., Vitis, C. D., Camero, S., Marchetti, C., Mancini, R., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1490-7 · Cited by 85
Role of Akt Activation in PARP Inhibitor Resistance in Cancer
Gallyas, F., Sümegi, B., & Szabó, C. (2020) · Cancers · doi:10.3390/cancers12030532 · Cited by 81
“In previous research papers, we demonstrated that PARP inhibition leads to Akt activation resulting in cyto- and mitochondria protecting actions [10].”
BackgroundSelf-citationThe PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks
Demény, M. Á., & Virág, L. (2021) · Cancers · doi:10.3390/cancers13092042 · Cited by 85
“This latter connection is important for the tissue-saving effects of PARPis in ischemiareperfusion models [75,76] and may also underlie cancer cell resistance to PARPis [77] or chemotherapeutics, such as paclitaxel [78].”
BackgroundAntao, S., Duong, T. T. H., Aran, R., & Witting, P. K. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2977 · Cited by 77
“Phosphorylated Akt targets to the mitochondria and inhibits the release of apoptosis-inducing factor and cytochrome c , thereby inhibiting apoptosis (7, 54).”
Involvement of PARP1 in the regulation of alternative splicing
Matveeva, E. A., Maiorano, J. N., Zhang, Q., Eteleeb, A. M., Convertini, P., Chen, J., Infantino, V., Stamm, S., Wang, J., Rouchka, E. C., et al. (2016) · Cell Discovery · doi:10.1038/celldisc.2015.46 · Cited by 72
“PJ34 was added to S2 cells in media, at fi nal concentrations of 300 n M and 10 μ M and incubated further for 10 h at growth temperature [29, 38].”
Paldino, E., D’Angelo, V., Laurenti, D., Angeloni, C., Sancesario, G., & Fusco, F. R. (2020) · Cells · doi:10.3390/cells9102286 · Cited by 69
“It has been shown that inhibition of PARP by specific compounds can prevent the release of AIF to the nucleus, and therefore promotes cell survival [33,34].”
BackgroundMetabolic roles of poly(ADP-ribose) polymerases
Vida, A., Márton, J., Mikó, E., & Bai, P. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.12.009 · Cited by 74
Zhou, H.-Z., Swanson, R. A., Simonis, U., Ma, X., Cecchini, G., & Gray, M. O. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00823.2005 · Cited by 65
“Alternatively, PARP-1 inhibition may stimulate mitochondrial protection and cellular survival through signal transduction pathways involving phosphatidylinositol 3-kinase and Akt (16, 24).”
BackgroundBartha, É., Solti, I., Kereskai, L., Lantos, J., Plózer, E., Magyar, K., Szabados, E., Kálai, T., Hideg, K., Halmosi, R., et al. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp144 · Cited by 67
Qin, W., Liu, G., Wang, J., Wang, H., Zhang, J., Zhang, F., Ma, Y., Ji, X., Li, C., & Zhang, M. (2016) · Oncotarget · doi:10.18632/oncotarget.8343 · Cited by 68
“PARP1 inhibition has been demonstrated to increase Akt phosphorylation in neuronal and liver cells exposed to oxidative stress [24].”
BackgroundRácz, B., Hantó, K., Tapodi, A., Solti, I., Kálmán, N., Jakus, P., Kovács, K., Debreceni, B., Gallyas, F., & Sümegi, B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.026 · Cited by 74
Self-citationCai, W., Chen, Y., Shi, L., Cheng, H. R., Banda, I., Ji, Y., Wang, Y., Li, X., Mao, Y., Zhang, D. F., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4101738 · Cited by 65
Mitochondrial Mechanisms of Neuroglobin’s Neuroprotection
Yu, Z., Poppe, J. L., & Wang, X. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/756989 · Cited by 64
“Phosphorylated Akt (p-Akt) inhibits the release of AIF and Cyt c, thereby inhibiting apoptosis [92], and thus the effect of Ngb in p-Akt may be another way of Ngb in regulating apoptosis.”
Pálfi, A., Tóth, A., Hantó, K., Deres, P., Szabados, E., Szereday, Z., Kulcsár, G., Kálai, T., Hideg, K., & Gallyas, F. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.03.427 · Cited by 60
“These findings also suggest that PARP inhibition could modulate these signaling pathways which are also participants in the development of cardiac hypertrophy [17,18].”
BackgroundSelf-citationMitochondrial Protection by PARP Inhibition
Gallyas, F., & Sümegi, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082767 · Cited by 59
“Due to PTEN’s rapid oxidative inactivation, most oxidative stress situations activate Akt for a period of time, although this activation is usually insufficient to protect the cells against the oxidative stress-induced mitochondrial and cellular damages [92,93].”
BackgroundSelf-citationQuantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer
Ryu, J., & Thomas, S. N. (2021) · Molecules · doi:10.3390/molecules26092674 · Cited by 66
“, KRAS mutant) [50], and activation of the PI3K/AKT pathway [51].”
BackgroundSaberi, B., Shinohara, M., Ybanez, M. D., Hanawa, N., Gaarde, W. A., Kaplowitz, N., & Han, D. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.90654.2007 · Cited by 58
“cell lines (54), was activated by H2O2 treatment.”
Preventing apoptotic cell death by a novel small heat shock protein
Bellyei, S., Szigeti, A., Pozsgai, É., Boronkai, Á., Gömöri, É., Hocsák, E., Farkas, R., Sümegi, B., & Gallyas, F. (2007) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2006.12.004 · Cited by 56
Self-citationSárszegi, Z., Bognar, E., Gaszner, B., Kónyi, A., Gallyas, F., Sümegi, B., & Berente, Z. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1252-8 · Cited by 60
Self-citationMester, L., Szabó, A., Atlasz, T., Szabadfi, K., Reglődi, D., Kiss, P., Rácz, B., Tamás, A., Gallyas, F., Sümegi, B., et al. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9049-6 · Cited by 58
“Inhibition of PARP can revert these processes, and in addition, it can activate one of the most important cytoprotective pathway, the PI-3-kinase-Akt system (Veres et al. 2003; Tapodi et al. 2005).”
BackgroundResultSelf-citationInduction of necrotic cell death and mitochondrial permeabilization by heme binding protein 2/SOUL
Szigeti, A., Bellyei, S., Gasz, B., Boronkai, Á., Hocsák, E., Minik, O., Bognár, Z., Várbiró, G., Sümegi, B., & Gallyas, F. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.10.067 · Cited by 53
“Cyt-c released from the mitochondria (B) during permeability transition was measured by HPLC exactly as previously [12].”
BackgroundMethodSelf-citationSaid, R. S., Mantawy, E. M., & El‐Demerdash, E. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01662-x · Cited by 51
Genome-scale CRISPR knockout screen identifies TIGAR as a modifier of PARP inhibitor sensitivity
Fang, P., Souza, C. D., Minn, K. T., & CHIEN, J. R. (2019) · Communications Biology · doi:10.1038/s42003-019-0580-6 · Cited by 52
PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol
Szántó, Á., Hellebrand, E., Bognár, Z., Tucsek, Z., Szabó, A., Gallyas, F., Sümegi, B., & Várbiró, G. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.01.008 · Cited by 55
Self-citationXiao, X., Zhang, C., Shao, M., Tong, Q., Zhang, G., Li, C., Cheng, J., Jin, S., Ma, J., Wang, G., et al. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/291087 · Cited by 50
Reda, A. M., Refaat, A., Abdrabou, A., Mahmoud, A. M., Adel, M., Sabet, S., & Ali, S. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-50141-z · Cited by 48
Poly(ADP-ribose) polymerase-1 protects neurons against apoptosis induced by oxidative stress
Díaz‐Hernandéz, J. I., Moncada, S., Bolaños, J. P., & Almeida, Á. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402117 · Cited by 51
“Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1-42)-mediated oxidative stress and neurotoxicity: implications for Alzheimer’s disease.”
BackgroundTherapeutic applications of PARP inhibitors in ovarian cancer
Xie, H., Wang, W., Xia, B., Jin, W., & Lou, G. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110204 · Cited by 52
Böhi, F., Manetsch, P., & Hottiger, M. O. (2021) · Cell Discovery · doi:10.1038/s41421-021-00323-9 · Cited by 47
Yeh, T.-Y. J., Meyer, T. N., Schwesinger, C., Tsun, Z.-Y., Lee, R. M., & Chi, N. (2006) · Biochemical Journal · doi:10.1042/bj20060713 · Cited by 49
Iizuka, M., Sasaki, K. A., Hirai, Y., Shindo, K., Konno, S., Itou, H., Ohshima, S., Horie, Y., & Watanabe, S. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00181.2006 · Cited by 46
“Namely, we investigated the activation of signaling proteins that belong to the MAPK and PI3 kinase-Akt pathways, since these signaling pathways have been shown to be closely involved in cell survival (4, 12, 34, 45, 53, 55).”
BackgroundResultVidimar, V., Gius, D. R., Chakravarti, D., Bulun, S. E., Wei, J., & Kim, J. J. (2016) · Science Advances · doi:10.1126/sciadv.1601132 · Cited by 49
Tucsek, Z., Radnai, B., Rácz, B., Debreceni, B., Priber, J. K., Dolowschiak, T., Palkovics, T., Gallyas, F., Sümegi, B., & Veres, B. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0610355 · Cited by 51
“LPS treatment [29, 30] and cellular oxidative stress [31] trigger MAPK activation, which in turn, leads to augmented production of proinflammatory cytokines [32].”
BackgroundSelf-citationPozsgai, É., Bellyei, S., Cseh, A. M., Boronkai, Á., Rácz, B., Szabó, A., Sümegi, B., & Hocsák, E. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2013.810291 · Cited by 44
Szigeti, A., Hocsák, E., Rapolti, E., Rácz, B., Boronkai, Á., Pozsgai, É., Debreceni, B., Bognár, Z., Bellyei, S., Sümegi, B., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.015222 · Cited by 46
Self-citationTapodi, A., Bognár, Z., Szabó, C., Gallyas, F., Sümegi, B., & Hocsák, E. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.10.005 · Cited by 46
Self-citationBeneke, S. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.04.008 · Cited by 50
“Inhibition of the activators of Akt, which belong to the phosphoinositol 3 kinase superfamily, by i.e., wortmannin totally abolished the beneficial effects of inhibiting poly(ADP ribose) polymerases in cells (Tapodi et al., 2005).”
Bellyei, S., Szigeti, A., Boronkai, Á., Pozsgai, É., Gömöri, É., Melegh, B., Janáky, T., Bognár, Z., Hocsák, E., Sümegi, B., et al. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0486-x · Cited by 41
“As we found previously [20], integrity of the mitochondrial membrane system represent a major factor in the resistance of the cell against oxidative stress induced damages.”
BackgroundMethodInfluentialSelf-citationDeres, L., Bartha, É., Pálfi, A., Erős, K., Riba, Á., Lantos, J., Kálai, T., Hideg, K., Sümegi, B., Gallyas, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102148 · Cited by 42
Self-citationKovács, K., Váczy, A., Fekete, K., Kovari, P., Atlasz, T., Reglődi, D., Gabriel, R., Gallyas, F., & Sümegi, B. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-25936 · Cited by 39
“These results are consistent with previous findings that inhibition of GSK-3b has protective effects in the retina,(44) and Akt activation is cytoprotective in oxidative stress situations.(45,46) In oxidative stress, PARP inhibition is reported to downregulate JNK and p38 MAPKs(12,26) that can also have a protective r…”
ResultSelf-citationMatthews, J. A., Belof, J. L., Acevedo-Duncan, M. E., & Potter, R. L. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9358-5 · Cited by 38
“In addition to osmotic stress, oxidative stress has also been shown to increase Akt activation [45, 46].”
BackgroundCasili, G., Campolo, M., Lanza, M., Filippone, A., Scuderi, S. A., Messina, S., Ardizzone, A., Esposito, E., & Paterniti, I. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02033-x · Cited by 38
“The inhibition of PARP induces activation of the cytoprotective PI3K-Akt pathway in oxidatively stressed cells, causing cytostatic resistance undermining its cytostatic effect [34, 63, 64].”
BackgroundNarita, M., Hatano, E., Ikai, I., Miyagawa‐Hayashino, A., Yanagida, A., Nagata, H., Asechi, H., Taura, K., & Üemoto, S. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181a38ed5 · Cited by 37
“Furthermore, we found that OLP activated (phosphorylated) Akt, which is known as a major regulator of cell survival and reported to protect mitochondrial membrane potential from reactive oxygen species and inactivates proapoptotic protein.(34) ZnPP abolished the activation of Akt, indicating that OLP-induced activatio…”
BackgroundPARP-1-induced cell death through inhibition of the MEK/ERK pathway in MNNG-treated HeLa cells
Éthier, C., Labelle, Y., & Poirier, G. G. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0127-z · Cited by 43
“Although it has been shown that Akt activation induced by PARP-1 inhibition can protect cells from oxidative stress [25], this pathway does not seem to be involved in alkylating agent-induced cell death.”
BackgroundCritical role of bad phosphorylation by Akt in cytostatic resistance of human bladder cancer cells.
Szántó, Á., Bognár, Z., Szigeti, A., Szabó, A., Farkas, L., & Gallyas, F. (2009) · PubMed · Cited by 38
Self-citationSpindel, O. N., Chen, Y., & Berk, B. C. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.244681 · Cited by 37
“shown that PARP1 inhibition activated prosurvival signals: Akt in hepatic carcinoma cells and VEGFR2 in EC.(26,31)”
BackgroundInfluentialPálfi, A., Bartha, É., Copf, L., Márk, L., Gallyas, F., Veres, B., Kálmán, E., Pajor, L., Tóth, K., Ohmacht, R., et al. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.04.009 · Cited by 33
“This pattern of activation of Akt was very similar to that found for PARP inhibitors in septic shock [34], oxidative stress [35] and ischemia-reperfusion [36] models for red wine polyphenols in an ischemia model [37] and for various cytoprotective agents in different stress-stimuli models.”
ResultSelf-citationThe potential of mitochondrial modulation by neuroglobin in treatment of neurological disorders
Gorabi, A. M., Aslani, S., Barreto, G. E., Báez-Jurado, E., Kiaie, N., Jamialahmadi, T., & Sahebkar, A. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.11.002 · Cited by 33
“Neuroglobin-induced phosphorylation of Akt prevents Cyt c and AIF release, resulting in apoptosis suppression [78].”
BackgroundWang, S., Wang, S., Song, Z., Liu, X.-W., Wang, R., & Zhao-fu, C. (2007) · Neuroreport · doi:10.1097/wnr.0b013e32826fb3a5 · Cited by 32
“Recently, 3-AB has been found to not only inhibit PARP, but also indirectly enhance cell-survival signals [8].”
BackgroundInfluentialReduced intestinal and renal amino acid transport in PDK1 hypomorphic mice
Rexhepaj, R., Grahammer, F., Völkl, H., Remy, C., Wagner, C. A., Sandulache, D., Artunç, F., Henke, G., Nammi, S., Capasso, G., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5676com · Cited by 32
Fighting resistance: post-PARP inhibitor treatment strategies in ovarian cancer
Veneziani, A. C., Scott, C. L., Wakefield, M. J., Tinker, A. V., & Lheureux, S. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359231157644 · Cited by 33
Li, W. J., Zhou, J., Li, B., Wang, H., Peng, Y. B., & Wang, Z. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02176.x · Cited by 30
Boronkai, Á., Bellyei, S., Szigeti, A., Pozsgai, É., Bognár, Z., Sümegi, B., & Gallyas, F. (2009) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2009.07.005 · Cited by 29
“In addition, it was reported that the PI-3K-Akt pathway plays a critical role in the protection of the integrity of the mitochondrial membrane system (Tapodi et al., 2005).”
BackgroundSelf-citationKovács, K., Hantó, K., Bognár, Z., Tapodi, A., Bognar, E., Kiss, G. N., Szabó, A., Rappai, G., Kiss, T., Sümegi, B., et al. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9929-8 · Cited by 29
“We have previously demonstrated that activation of the cytoprotective PI-3 kinase/Akt pathway significantly contributed to cardioprotective [13] and cytoprotective [ 5 ] effects of PARP inhibition.”
BackgroundSelf-citationHuang, F. (2009) · Mediators of Inflammation · doi:10.1155/2009/103890 · Cited by 30
Pang, J., Gong, H., Xi, C., Fan, W., Dai, Y., & Zhang, T. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22919 · Cited by 28
“The inhibition of Akt activation by PARP1, which involved in cell survival modulation, had also been elucidated in other papers [Tapodi et al., 2005; Szanto et al., 2009].”
ResultTiwari, P., Khan, H., Singh, T. G., & Grewal, A. K. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03595-z · Cited by 29
“It has been recognized that various regulatory proteins, such as caspase-9 and GSK3, undergo phosphorylation through Akt that, under stress environments, protect the cells [112].”
BackgroundInfluentialMagyar, K., Deres, L., Erős, K., Bruszt, K., Seress, L., Hamar, J., Hideg, K., Balogh, A., Gallyas, F., Sümegi, B., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.03.008 · Cited by 33
Self-citationPARP inhibition and postinfarction myocardial remodeling
Halmosi, R., Deres, L., Gál, R., Erős, K., Sümegi, B., & Tóth, K. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.223 · Cited by 30
“promoting mitochondrial damage [35] can further induce ROS production, elevated intracellular Ca 2+ and destabilize the mitochondrial membrane system leading to mitochondrial permeability transition and cell death [32, 33].”
Bartha, É., Kiss, G. N., Kálmán, E., Kulcsár, G., Kálai, T., Hideg, K., Habon, T., Sümegi, B., Tóth, K., & Halmosi, R. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181855cef · Cited by 28
“Our previous data showed that PARP inhibitors were able to reduce the oxidative damage of cellular components.(15,24) It was showed that PARP was activated in the reperfused myocardium in animals,(25) and it was also recently proven in human failing heart samples.”
BackgroundQiao-zhuan, L., Li, M., Wang, Y.-L., Fauzee, N. J. S., Yang, Y., Pan, J., Yang, L., & Lazar, A. J. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000338491 · Cited by 27
Xiang, C., Zhang, M.-L., Zhao, Q., Xie, Q., Yan, H., Yu, X., Wang, P., & Wang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.14578 · Cited by 27
“In a recent study, artificial knockdown of high PARP-1 expression under oxidative stress was responsible for the protection of mitochondria to maintain cell survival [38].”
BackgroundCseh, A. M., Fábián, Z., Sümegi, B., & Scorrano, L. (2017) · Oncotarget · doi:10.18632/oncotarget.16859 · Cited by 27
Yamamoto, Y., Enkhbaatar, P., Sousse, L. E., Sakurai, H., Rehberg, S. W., Asmussen, S., Kraft, E. R., Wright, C. L., Bartha, É., Cox, R. A., et al. (2012) · Shock · doi:10.1097/shk.0b013e3182459482 · Cited by 27
“Poly(ADP-ribose) polymerase activity was determined by measuring PAR protein, the product or the reaction (28, 29).”
TIP47 protects mitochondrial membrane integrity and inhibits oxidative‐stress‐induced cell death
Hocsák, E., Rácz, B., Szabo, A., Mester, L., Rapolti, E., Pozsgai, É., Jávor, S., Bellyei, S., Gallyas, F., Sümegi, B., et al. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.027 · Cited by 25
“Immunoblots were blocked, and developed with polyclonal anti-TIP47 antibody [13] or polyclonal antibodies against the GA3PD, PDC-1a, Histon H1 proteins; and horseradish-peroxidase-labeled secondary immunoglobulin G as described in [15].”
MethodSelf-citationLakatos, P., Szabó, É., Hegedűs, C., Haskó, G., Gergely, P., Bai, P., & Virág, L. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.12.003 · Cited by 25
Targeted Therapy for Brain Tumours: Role of PARP Inhibitors
Leonetti, C., Biroccio, A., Graziani, G., & Tentori, L. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912799277403 · Cited by 27
Cseh, A. M., Fábián, Z., Quintana–Cabrera, R., Szabó, A., Erős, K., Soriano, M. E., Gallyas, F., Scorrano, L., & Sümegi, B. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00538 · Cited by 24
Self-citationPARP1 inhibition protects mice against Japanese encephalitis virus infection
Desingu, P. A., Mishra, S., Dindi, L., Srinivasan, S., Rajmani, R. S., Ravi, V., Tamta, A. K., Raghu, S., Murugasamy, K., Pandit, A. S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113103 · Cited by 24
Pozsgai, É., Gömöri, É., Szigeti, A., Boronkai, Á., Gallyas, F., Sümegi, B., & Bellyei, S. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-233 · Cited by 23
“Isolation of cytosol and nuclear fractions were carried out by standard lab protocols exactly as previously [13].”
MethodSelf-citationYang, X., Zhao, K., Deng, W., Zhao, L., Jin, H., Mei, F., Zhou, Y., Li, M., & Wang, W. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05892-0 · Cited by 23
Metadata
- Authors
- Tapodi, A., Debreceni, B., Hanto, K., Bognar, Z., Wittmann, I., Gallyas, F., Varbiro, G., & Sumegi, B.
- Affiliations
- University of Pecs (HU)
- ORCID
- Gallyas, Ferenc
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-10
- Volume
- 280
- Issue
- 42
- Pages
- 35767-35775
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2075491707
- Cited by
- 166
- References
- 58
- Citations by year
- 2025: 5 · 2024: 5 · 2023: 3 · 2022: 10 · 2021: 6 · 2020: 11 · 2019: 10 · 2018: 4 · 2017: 7 · 2016: 8 · 2015: 6 · 2014: 8 · 2013: 10 · 2012: 14
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5480 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- PARP1 inhibition, Akt activation, oxidative stress, mitochondrial protection, cell survival, PI3K signaling, mitochondrial membrane potential, hydrogen peroxide, single-strand breaks, ADP-ribosylation, Src kinase, cytoprotection, WRL-68 cells
- MeSH terms
- Acetylcysteine, Cell Line, Cell Survival, Enzyme Activation, Enzyme Inhibitors, Humans, Hydrogen Peroxide, Liver, Membrane Potentials, Microscopy, Fluorescence, Mitochondria, Models, Biological, Necrosis, Phosphorylation, Poly(ADP-ribose) Polymerases, Time Factors, Blotting, Western, Protein Structure, Tertiary, Oxidative Stress, Phosphatidylinositol 3-Kinases, RNA, Small Interfering, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.